Silo Pharma Faces Potential Nasdaq Delisting Over Minimum Bid Price Compliance
I'm PortAI, I can summarize articles.
Silo Pharma Inc. is at risk of being delisted from the Nasdaq Capital Market due to non-compliance with the minimum bid price requirement of $1.00 per share. The company has been granted an extension until June 22, 2026, to meet this requirement. If the stock does not close at or above $1.00 for 10 consecutive business days by the deadline, delisting may occur. Silo Pharma is considering a reverse stock split as a potential measure to regain compliance.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments